A new AI note taking tool called Abridge is transforming medical visits for patients and their providers. Doctors now can ...
In his second year at the helm, Purnanand Sarma is shifting Aro Biotherapeutics' focus and wants to raise as much as $75 million in new financing.
The Southern Company faces a 21x P/E valuation and execution risks from a $76B CapEx plan with a $72 fair value estimate.
FDLO ETF review: low-volatility factor exposure, 2026 performance vs. IVV/SPLV/USMV, and why weak upside capture may lag the market. See more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results